Xenon Pharmaceuticals Inc... (XENE)

NASDAQ: XENE · Real-Time Price · USD

38.18

-0.02 (-0.05%)

At close: May 01, 2025, 3:59 PM

37.91

-0.71%

Pre-market: May 02, 2025, 06:45 AM EDT

Xenon Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-234.33M	-182.39M	-125.37M	-78.88M	-28.84M	-41.59M	-34.5M	-30.7M	-23M
Depreciation & Amortization	n/a	3.54M	1.62M	906K	644K	429K	586K	649K	864K
Stock-Based Compensation	50.72M	32.37M	20.38M	10.02M	5.68M	2.92M	2.63M	2.24M	2.16M
Other Working Capital	n/a	1.57M	-10.49M	-2.19M	-25.06M	34.17M	-145K	178K	529K
Other Non-Cash Items	11.09M	-4.19M	5.66M	1.05M	766K	223K	-4.11M	11K	-63K
Deferred Income Tax	-8.86M	-292K	-44K	58K	-285K	-133K	646K	-1.47M	-1.3M
Change in Working Capital	n/a	5.63M	-676K	-2.65M	-26.09M	33.52M	30K	556K	1.77M
Operating Cash Flow	-181.39M	-145.33M	-98.43M	-69.5M	-48.12M	-4.63M	-34.72M	-28.73M	-19.57M
Capital Expenditures	-3.08M	-5.62M	-2.89M	-2.05M	-2.64M	-1.24M	-507K	-315K	-279K
Cash Acquisitions	n/a	n/a	296M	-144.75M	-214.71M	-75.44M	-48.52M	-52.62M	n/a
Purchase of Investments	n/a	-793.91M	-551.14M	-389.47M	-228.9M	-140.49M	-77M	-28.01M	-47.56M
Sales Maturities Of Investments	n/a	682.35M	258.03M	144.75M	214.71M	75.44M	48.52M	52.62M	n/a
Other Investing Acitivies	165M	n/a	-296M	144.75M	214.71M	75.44M	48.52M	52.62M	-47.56M
Investing Cash Flow	165M	-117.17M	-296M	-246.77M	-16.82M	-66.29M	-28.99M	24.29M	-47.84M
Debt Repayment	n/a	n/a	n/a	n/a	-16.74M	n/a	8.45M	6.89M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	47K	35K	705K	260K	82K	122K	288K	177K	132K
Financial Cash Flow	12.13M	353.52M	278.47M	447.54M	85.8M	27.52M	111.59M	7.07M	23.96M
Net Cash Flow	-5.93M	91.4M	-118.45M	130.68M	20.25M	-43M	47.27M	3.39M	-41.56M
Free Cash Flow	-184.46M	-150.94M	-101.32M	-71.55M	-50.76M	-5.87M	-35.23M	-29.04M	-19.85M